GlassScriptPhysician profile
Christopher D Sanders
NPI 1750729810
$2,938.53
in general payments reported to CMS, 2019-2025
15 companies · $79.19 in 2025
The $79.19 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,712 · 2020: $292 · 2021: $166 · 2022: $362 · 2023: $225 · 2024: $103 · 2025: $79.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $1,641.55 | 2019 | |
| Boston Scientific Corporation | $369.40 | 2020-2025 | General - Embolics, Cryoablation Needles, Embold Fibered |
| Inari Medical, INC. | $347.71 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $115.15 | 2022-2023 | Tagrisso, Lynparza |
| Ipsen Biopharmaceuticals, INC | $83.90 | 2020-2024 | Onivyde |
| Angiodynamics, INC. | $70.34 | 2019 | |
| Cook Medical LLC | $62.19 | 2023-2025 | Cook, Zilver Ptx |
| E.R. Squibb & Sons, L.L.C. | $49.56 | 2022-2023 | Opdivo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.65 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $34.52 | 2021-2022 | |
| Daiichi Sankyo INC. | $29.47 | 2024 | Enhertu |
| Incyte Corporation | $28.32 | 2022-2023 | Pemazyre, Monjuvi |
| Celgene Corporation | $21.51 | 2023 | Opdualag |
| Medtronic, INC. | $20.89 | 2025 | Emprint |
| Glaxosmithkline, LLC. | $15.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.